- Benzinga•13 hours ago
After a meeting with President-elect Donald Trump, Bayer AG (ADR) (OTC: BAYRY ) generated excitement among American investors eager to finalize a long-anticipated merger with Monsanto Company (NYSE: MON ...
- Barrons.com•16 hours ago
Abbott Laboratories (ABT: NYSE) By Wells Fargo Securities ($40.76, Jan. 18, 2017) Following the closing of the St. Jude Medical acquisition on Jan. 4, we have updated our Abbott Laboratories model and ...
- Insider Monkey•2 days agoACCURATE Study Confirms Superiority Of Abbott Laboratories (ABT) Dorsal Root Ganglion (DRG) Stimulation
Abbott Laboratories (NYSE:ABT)‘s dorsal root ganglion (DRG) stimulation therapy has advantages over traditional spinal cord stimulation (SCS) in the treatment of patients suffering from complex regional pain syndrome (CRPS). This is according to the latest data that was published in the January edition of Pain. The publication highlighted the real-world insight both in a short-term […]
ABT : Summary for Abbott Laboratories Common Stoc - Yahoo Finance
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||40.24 - 40.73|
|52 Week Range||36.00 - 45.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||26.67|
|Dividend & Yield||1.06 (2.60%)|
|1y Target Est||N/A|